Cargando…
Infrared spectroscopy analysis determining secondary structure change in albumin by cerium oxide nanoparticles
Cerium oxide (CeO(2)) nanoparticles are expected to have applications in the biomedical field because of their antioxidative properties. Inorganic nanoparticles interact with proteins at the nanoparticle surface and change their conformation when administered; however, the principle underlying this...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561088/ https://www.ncbi.nlm.nih.gov/pubmed/37818288 http://dx.doi.org/10.3389/ftox.2023.1237819 |
_version_ | 1785117848576720896 |
---|---|
author | Umezawa, Masakazu Itano, Ryodai Sakaguchi, Naoya Kawasaki, Takayasu |
author_facet | Umezawa, Masakazu Itano, Ryodai Sakaguchi, Naoya Kawasaki, Takayasu |
author_sort | Umezawa, Masakazu |
collection | PubMed |
description | Cerium oxide (CeO(2)) nanoparticles are expected to have applications in the biomedical field because of their antioxidative properties. Inorganic nanoparticles interact with proteins at the nanoparticle surface and change their conformation when administered; however, the principle underlying this interaction is still unclear. This study aimed to investigate the secondary structural changes occurring in bovine serum albumin (BSA) mixed with CeO(2) nanoparticles having different surface modifications using Fourier transform infrared spectroscopy. CeO(2) nanoparticles (diameter: 240 nm) were synthesized from an aqueous cerium (III) nitrate solution using a homogeneous precipitation method. The surfaces of the nanoparticles were modified by the catechol compounds dopamine and 3,4-dihydroxyhydrocinnamic acid (DHCA). In the presence of these CeO(2) nanoparticles (0.11–0.43 mg/mL), β-sheet formation of BSA (30 mg/mL) was promoted especially on the amine-modified (positively charged) nanoparticles. The local concentration of BSA on the surface of the positively charged nanoparticles may have resulted in structural changes due to electrostatic and other interactions with BSA. Further investigations of the interaction mechanism between nanoparticles and proteins are expected to lead to the safe biomedical applications of inorganic nanoparticles. |
format | Online Article Text |
id | pubmed-10561088 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105610882023-10-10 Infrared spectroscopy analysis determining secondary structure change in albumin by cerium oxide nanoparticles Umezawa, Masakazu Itano, Ryodai Sakaguchi, Naoya Kawasaki, Takayasu Front Toxicol Toxicology Cerium oxide (CeO(2)) nanoparticles are expected to have applications in the biomedical field because of their antioxidative properties. Inorganic nanoparticles interact with proteins at the nanoparticle surface and change their conformation when administered; however, the principle underlying this interaction is still unclear. This study aimed to investigate the secondary structural changes occurring in bovine serum albumin (BSA) mixed with CeO(2) nanoparticles having different surface modifications using Fourier transform infrared spectroscopy. CeO(2) nanoparticles (diameter: 240 nm) were synthesized from an aqueous cerium (III) nitrate solution using a homogeneous precipitation method. The surfaces of the nanoparticles were modified by the catechol compounds dopamine and 3,4-dihydroxyhydrocinnamic acid (DHCA). In the presence of these CeO(2) nanoparticles (0.11–0.43 mg/mL), β-sheet formation of BSA (30 mg/mL) was promoted especially on the amine-modified (positively charged) nanoparticles. The local concentration of BSA on the surface of the positively charged nanoparticles may have resulted in structural changes due to electrostatic and other interactions with BSA. Further investigations of the interaction mechanism between nanoparticles and proteins are expected to lead to the safe biomedical applications of inorganic nanoparticles. Frontiers Media S.A. 2023-09-25 /pmc/articles/PMC10561088/ /pubmed/37818288 http://dx.doi.org/10.3389/ftox.2023.1237819 Text en Copyright © 2023 Umezawa, Itano, Sakaguchi and Kawasaki. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Toxicology Umezawa, Masakazu Itano, Ryodai Sakaguchi, Naoya Kawasaki, Takayasu Infrared spectroscopy analysis determining secondary structure change in albumin by cerium oxide nanoparticles |
title | Infrared spectroscopy analysis determining secondary structure change in albumin by cerium oxide nanoparticles |
title_full | Infrared spectroscopy analysis determining secondary structure change in albumin by cerium oxide nanoparticles |
title_fullStr | Infrared spectroscopy analysis determining secondary structure change in albumin by cerium oxide nanoparticles |
title_full_unstemmed | Infrared spectroscopy analysis determining secondary structure change in albumin by cerium oxide nanoparticles |
title_short | Infrared spectroscopy analysis determining secondary structure change in albumin by cerium oxide nanoparticles |
title_sort | infrared spectroscopy analysis determining secondary structure change in albumin by cerium oxide nanoparticles |
topic | Toxicology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561088/ https://www.ncbi.nlm.nih.gov/pubmed/37818288 http://dx.doi.org/10.3389/ftox.2023.1237819 |
work_keys_str_mv | AT umezawamasakazu infraredspectroscopyanalysisdeterminingsecondarystructurechangeinalbuminbyceriumoxidenanoparticles AT itanoryodai infraredspectroscopyanalysisdeterminingsecondarystructurechangeinalbuminbyceriumoxidenanoparticles AT sakaguchinaoya infraredspectroscopyanalysisdeterminingsecondarystructurechangeinalbuminbyceriumoxidenanoparticles AT kawasakitakayasu infraredspectroscopyanalysisdeterminingsecondarystructurechangeinalbuminbyceriumoxidenanoparticles |